MARATTO

article · Microbes Infection and Chemotherapy

Antibiogram and Molecular Characterization of Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae in a Nigerian Teaching Hospital

20253 citationsOpen accessGombe State University

Abstract

Background: Klebsiella pneumoniae is a gram-negative bacterium responsible for infections like urinary tract infections (UTIs) and is a leading cause of nosocomial infections in immunocompromised patients. Data on resistance profiles in Nigeria is limited. This study investigated the antibiogram and molecular characteristics of ESBL-producing Klebsiella pneumoniae at the University of Medical Sciences Teaching Hospital, Ondo State. Methods: A cross-sectional study analyzed 300 samples from urine, sputum, and wound infections. Isolates were cultured on MacConkey agar, followed by biochemical tests. The Kirby-Bauer method assessed resistance, and the double-disk synergy test confirmed ESBL production. PCR identified blaTEM, blaSHV, and blaCTX-M genes. SPSS was used for statistical analysis (P < 0.05). Results: Of 300 samples, 185 showed bacterial growth, with 54 confirmed as Klebsiella pneumoniae. Among these, 22 were multidrug-resistant (MDR), and 8 (14.8%) were ESBL producers. The blaTEM gene was present in all ESBL isolates, and the blaSHV gene in 7 of 8 (87.5%). Resistance to β-lactam antibiotics and aminoglycosides was high. Older patients and prolonged hospital stays correlated with higher MDR rates. A slight female predominance was noted. Conclusions: The high prevalence of MDR Klebsiella pneumoniae highlights the need for enhanced surveillance and deeper understanding of resistance patterns in the region.

Research topics

  • Antibiotic Use and Resistance
  • Antibiotic Resistance in Bacteria

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.54034/mic.e2305

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.